AU2001239921A1 - Antibody inhibiting the binding between GP120 and DC-SIGN and screening methods - Google Patents
Antibody inhibiting the binding between GP120 and DC-SIGN and screening methodsInfo
- Publication number
- AU2001239921A1 AU2001239921A1 AU2001239921A AU2001239921A AU2001239921A1 AU 2001239921 A1 AU2001239921 A1 AU 2001239921A1 AU 2001239921 A AU2001239921 A AU 2001239921A AU 2001239921 A AU2001239921 A AU 2001239921A AU 2001239921 A1 AU2001239921 A1 AU 2001239921A1
- Authority
- AU
- Australia
- Prior art keywords
- sign
- binding
- screening methods
- antibody inhibiting
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 title 1
- 102000004965 antibodies Human genes 0.000 title 1
- 108090001123 antibodies Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/517,605 | 2000-03-02 | ||
US09/517,605 US6391567B1 (en) | 2000-03-02 | 2000-03-02 | Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
PCT/US2001/006322 WO2001064752A2 (en) | 2000-03-02 | 2001-02-28 | Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001239921A1 true AU2001239921A1 (en) | 2001-11-22 |
AU2001239921B2 AU2001239921B2 (en) | 2006-11-23 |
Family
ID=24060480
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001239921A Ceased AU2001239921B2 (en) | 2000-03-02 | 2001-02-28 | Antibody inhibiting the binding between GP120 and DC-SIGN and screening methods |
AU3992101A Pending AU3992101A (en) | 2000-03-02 | 2001-02-28 | Methods of using a facilitator of retroviral entry into cells |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU3992101A Pending AU3992101A (en) | 2000-03-02 | 2001-02-28 | Methods of using a facilitator of retroviral entry into cells |
Country Status (6)
Country | Link |
---|---|
US (2) | US6391567B1 (en) |
EP (1) | EP1263789A2 (en) |
JP (1) | JP2004536777A (en) |
AU (2) | AU2001239921B2 (en) |
CA (1) | CA2402054A1 (en) |
WO (1) | WO2001064752A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7208152B2 (en) | 1999-11-24 | 2007-04-24 | Millennium Pharmaceuticals, Inc. | Antibodies for “Bonzo” chemokine receptor and therapeutic uses thereof |
US6319675B1 (en) | 1999-11-24 | 2001-11-20 | Millennium Pharmaceuticals, Inc. | Methods for detecting and/or identifying agents which bind and/or modulate function of “bonzo” chemokine receptor |
US7022323B2 (en) * | 2001-06-26 | 2006-04-04 | Progenics Pharmaceuticals, Inc. | Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
US20030232745A1 (en) * | 2001-06-26 | 2003-12-18 | Olson William C. | Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection |
US20040142891A1 (en) * | 2001-08-16 | 2004-07-22 | Universiteit Utrecht | Genes involved in immune related responses observed with asthma |
US20050221291A1 (en) * | 2002-05-03 | 2005-10-06 | Board Of Regents, The University Of Texas System | Dc-sign isoforms, related compositions and methods for their use in disease therapy |
ES2197826B1 (en) * | 2002-06-21 | 2005-04-01 | Consejo Superior De Investigaciones Cientificas | THERAPEUTIC COMPOUND AGAINST INFECTION WITH LEISHMANIA AND ITS USE. |
US7427469B2 (en) * | 2002-11-05 | 2008-09-23 | Institut Pasteur | Method of treating cytomegalovirus with DC-SIGN blockers |
ATE428437T1 (en) * | 2002-11-05 | 2009-05-15 | Pasteur Institut | DC-SIGN BLOCKERS AND THEIR USE TO PREVENT OR TREAT VIRAL INFECTIONS |
WO2005000219A2 (en) * | 2003-05-28 | 2005-01-06 | The Board Of Trustees Of The University Of Illinois | Composition for blocking hiv binding to dendritic cells and methods of use thereof |
GB0318247D0 (en) * | 2003-08-05 | 2003-09-10 | Royal Veterinary College | Antigen delivery system |
WO2005040823A1 (en) * | 2003-10-24 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 15 (gpr15) |
US8202523B2 (en) * | 2005-09-22 | 2012-06-19 | ProSci, Inc. | Glycosylated polypeptides produced in yeast mutants and methods of use thereof |
US20090214510A1 (en) * | 2006-02-21 | 2009-08-27 | Government Of The Us As Represented By The Secretary, Department Of Health And Human Services | Broad Spectrum Antiviral Compositions |
AU2008319384A1 (en) | 2007-10-29 | 2009-05-07 | Virginia Tech Intellectual Properties, Inc. | Porcine DC-SIGN , ICAM-3 and LSECtin and uses thereof |
WO2014151771A1 (en) * | 2013-03-14 | 2014-09-25 | The J. David Gladstone Institutes | Compositions and methods for treating an immunodeficiency virus infection |
WO2019143631A1 (en) * | 2018-01-16 | 2019-07-25 | Phoenix Biomolecular Engineering Foundation | Universal viral vaccines |
KR20210043483A (en) * | 2018-03-05 | 2021-04-21 | 온코이뮨, 아이앤씨. | How to Use Soluble CD24 to Treat Acquired Immunodeficiency Syndrome (HIV/AIDS) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6255555B1 (en) * | 1997-04-17 | 2001-07-03 | Japan Science And Technology Corporation | Transgenic mouse expressing human fusin and human CD4 |
WO1999003888A1 (en) * | 1997-07-17 | 1999-01-28 | New York University | Alternate receptors associated with retroviral entry into cells |
-
2000
- 2000-03-02 US US09/517,605 patent/US6391567B1/en not_active Expired - Lifetime
-
2001
- 2001-02-28 EP EP01914547A patent/EP1263789A2/en not_active Withdrawn
- 2001-02-28 AU AU2001239921A patent/AU2001239921B2/en not_active Ceased
- 2001-02-28 JP JP2001564245A patent/JP2004536777A/en active Pending
- 2001-02-28 CA CA002402054A patent/CA2402054A1/en not_active Abandoned
- 2001-02-28 WO PCT/US2001/006322 patent/WO2001064752A2/en active Application Filing
- 2001-02-28 AU AU3992101A patent/AU3992101A/en active Pending
-
2002
- 2002-05-20 US US10/151,274 patent/US20030064071A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001250049A1 (en) | Non-spherical whispering-gallery-mode microactivity | |
AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
AU1290001A (en) | Antibodies | |
AU2001261630A1 (en) | Audio closure | |
AU2001251486A1 (en) | Aerosol enhancement device | |
AU2002213831A1 (en) | Actuating member and method for producing the same | |
AU2001282890A1 (en) | Immunosensor | |
AU2001296619A1 (en) | Improved stopcock | |
AU2001239921A1 (en) | Antibody inhibiting the binding between GP120 and DC-SIGN and screening methods | |
AU2001234125A1 (en) | Antibody library | |
AU4935000A (en) | Antibodies | |
AU2001280599A1 (en) | Compounds and methods | |
EP1344576B8 (en) | Inline sifter | |
AU2001253418A1 (en) | Compounds and methods | |
IL206832A0 (en) | Antibodies binding an 161p2f10b epitope and uses thereof | |
AU2002365649A1 (en) | Anti-dota antibody | |
EP1469316A2 (en) | Screening method | |
AU2002231295A1 (en) | Developed seed and methods for making the same | |
AU2001243394A1 (en) | Compounds and methods | |
AU2001296709A1 (en) | Gemstone | |
AU2002223963A1 (en) | Transaction certification | |
AUPQ872300A0 (en) | Compounds and methods | |
AU2001294274A1 (en) | Antibody inhibiting VPLF activity | |
AU2001295582A1 (en) | Tumour-related antigens | |
AU2001278951A1 (en) | Compounds and methods |